DBV Technologies skyrockets after FDA lifts hold on VITESSE trial Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- News Corp. (NWSA) up 4% after Axios reported that Michael Bloomberg is looking to expand his media empire and is interested in buying either Dow Jones, the parent company of The Wall Street Journal, or The Washington Post
- DBV Technologies (DBVT) up 33% after announcing that the FDA has lifted the partial clinical hold on the company's VITESSE Phase 3 clinical trial that will evaluate the modified Viaskin Peanut 250 microgram patch in peanut-allergic children ages 4 to 7 years
- Tesla (TSLA) up 1% after CEO Elon Musk said he will pause his share sales for another two years
- Toro Company (TTC) up 2% after Raymond James analyst Sam Darkatsh upgraded shares to Outperform
DOWN AFTER EARNINGS -
- Mission Produce (AVO) down 14%
- Limoneira (LMNR) down 13%
LOWER -
- Nutanix (NTNX) down 13% after Dealreporter said that HP Enterprise's (HPE) interest in a possible takeover of the company has cooled and the companies are no longer engaged in discussions
- AMC Entertainment (AMC) continues to fall as shares drop 5% further in pre-market trading after yesterday's announcement of a $110M equity capital raise
Symbols:
DBVT TSLA - $125.34 /
-12.0899 (-8.80%)
TTC AVO LMNR NTNX AMC NWSA NWS HPE Keywords: Fly Intel, Wall Street, Top Stories, Stocks